Fractyl is a leader in creating innovative treatments to address the root cause of type 2 diabetes. Leveraging our groundbreaking insights about the role of the intestine in metabolic disease, we are developing and commercializing entirely new treatment approaches to type 2 diseases and other metabolic diseases.
Fractals are complex patterns created by simple processes. Such patterns are seen throughout nature, from snowflakes to lightning bolts. The name Fractyl reflects the fact that metabolic diseases, though seemingly complex, can be simply understood from their roots in the duodenum.Learn more about the duodenum
Our leaders have a wealth of expertise across all stages of therapeutic development and commercialization. Through our accomplished Board of Directors, investors, and scientific advisors, we have access to some of the most insightful minds in the global scientific and biopharma landscape.